Europe’s medical regulator has opened an investigation into possible links between Johnson & Johnson’s (JNJ) COVID-19 vaccine and blood clotting events.
The European Medicines Agency (EMA) said in a statement on Friday it had started a “review” of the safety of the COVID-19 vaccine developed by J&J subsidiary Janssen, following reports that some patients who had…
Source link
